
Broadcast Of 2021 – Dr. Peter McCullough Live In Studio & More - “This is a Test of Scientific Integrity” Must See Comprehensive Data Transparency
Spike Protein Pathogenicity, Genetic Transfer Technology and Exosomes
The COVID-19 vaccines utilize genetic transfer technology to trick human ribosomes into producing the pathogenic spike protein originally engineered in a Wuhan lab. Research by Sanjaya Bansal shows that these spike proteins circulate in the body within exosomes for extended periods. Unlike traditional vaccines, these injections bypass the body's natural mucosal defenses in the nose and mouth.

